Filing Details
- Accession Number:
- 0000879169-24-000130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-17 12:24:01
- Reporting Period:
- 2024-07-15
- Accepted Time:
- 2024-07-17 12:24:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1615842 | P Barry Flannelly | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Manager Us | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-15 | 9,925 | $0.00 | 60,459 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-07-15 | 1,111 | $64.25 | 59,348 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-07-16 | 1,306 | $64.19 | 58,042 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-07-15 | 22,205 | $0.00 | 22,205 | $64.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,205 | 2034-07-14 | No | 4 | A | Direct |
Footnotes
- Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to the employee's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
- Including the July 15, 2024 grant, this includes an aggregate of 46,105 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
- The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Billionaire Hedge Funds
